Asked by: Dean Russell (Conservative - Watford)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, if she will make an assessment of the potential merits of amending the Data Protection and Digital Information Bill to extend the list of cookie exemptions to include (a) advertising performance and (b) audience measurement cookies.
Answered by Julia Lopez - Minister of State (Department for Science, Innovation and Technology)
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Asked by: Dean Russell (Conservative - Watford)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, if he will make it his policy to amend Universal Credit regulations to take into account the 53-week rent year for 2024.
Answered by Mims Davies - Minister of State (Department for Work and Pensions)
Universal Credit payments are designed to mirror the world of work, with calendar monthly calculations and payments reflecting the way most working people are paid.
As no calendar year contains 53 weeks, Universal Credit always converts weekly amounts to monthly sums using 52 weeks. The legitimacy of this approach was confirmed by the High Court having been tested via a judicial review.
All of our policies are open to review and may be subject to change in the future; however, we have no plans at present to make changes to this policy.
Asked by: Dean Russell (Conservative - Watford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, which part of NHS England has accountability for coeliac disease diagnoses.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Integrated care boards (ICB) commission services to meet the needs of their local populace. Diagnosis of coeliac disease falls within the portfolio of ICB-commissioned services. As such, NHS England does not have central accountability. However, NHS England has invested in senior clinical leadership in gastroenterology, which includes coeliac disease, as a priority workstream in the national Getting It Right First Time programme.
The diagnosis of coeliac disease commonly involves a blood test and, in some cases, a biopsy of the small intestine. Post-diagnosis, further blood tests, which check the levels of iron and other vitamins and minerals, may be required to assess how the condition has affected the individual, such as the potential for iron deficiency anaemia due to poor absorption of nutrients. A bone density scan may also be recommended if the condition is thought to affect the individual’s bones.
Asked by: Dean Russell (Conservative - Watford)
Question to the Home Office:
To ask the Secretary of State for the Home Department, what progress he has made on developing Domestic Abuse Matters training for officers investigating domestic abuse offences.
Answered by Laura Farris - Parliamentary Under Secretary of State (Ministry of Justice) (jointly with Home Office)
The Domestic Abuse Matters training programme has now been delivered to over 80% of police forces to date, including Hertfordshire Police. The College of Policing guidance for the Domestic Abuse Matters training specifies 75% of all first responders to domestic abuse must be trained to effect mass behavioural change.
The Home Office has also funded the College of Policing to develop a new module of Domestic Abuse Matters training, targeted specifically at officers investigating domestic abuse offences to enable further improvement in police responses to domestic abuse incidents.
The Home Office will continue to work with the College of Policing to ensure the training reflects our most up to date understanding of domestic abuse.
Asked by: Dean Russell (Conservative - Watford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent progress NHS England has made on developing a neuropsychiatric service specification.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
NHS England remains committed to the continued development and improvement of all services, including neuropsychiatry. Neuropsychiatry covers a broad spectrum of mental health support, for people with a broad spectrum of neurological conditions, and as such, provision of neuropsychiatry falls within the care pathway of a range of services.
The provision of neuropsychiatry is included in, and will be strengthened within, the updated neurology service specification, neurosurgery specification, and complex rehabilitation service specification. The requirement and scope of a standalone neuropsychiatry service specification is being discussed with the Royal College of Psychiatry and mental health colleagues.
The Neurology Clinical Reference Group (CRG) will continue to lead this work and take forward discussions with the Royal College of Psychiatry, which is represented on both the Neurology CRG and Complex Rehabilitation and Disability CRG, and is contributing to the development of the service specifications listed above.
Asked by: Dean Russell (Conservative - Watford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what support exists for those with (a) Huntington’s disease and (b) other complex neurological conditions.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Integrated care boards (ICBs) are responsible for commissioning most services for people with neurological conditions, including those with Huntington’s disease. At a national level, NHS England commissions the specialised elements of neurological care that patients may receive from 27 specialised neurological treatment centres across England. NHS England’s RightCare toolkit and Getting It Right First Time programme aim to improve care for people with neurological conditions, by reducing variation and delivering care more equitably across England.
New optimal clinical pathways for a range of neurological conditions were developed by the National Neurosciences Advisory Group, which ceased operation in 2022. These pathways set out what good treatment, care, and support should look like across a range of neurological conditions. They also help to guide and facilitate the commissioning of high-quality, effective neurology services by ICBs. The optimal clinical pathway for movement disorders outlines the care pathway that patients with Huntington’s disease should receive. Further information on the optimal clinical pathways are available at the following link:
https://www.nnag.org.uk/optimum-clinical-pathways
The Department funds research on neurological conditions through the National Institute for Health and Care Research (NIHR), and between 2018/19 and 2022/23, the Department spent £272.1 million on research into neurological conditions. This covers research into conditions such as Huntington’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis. In 2022/23, the most recent year for which we have data, the Department, via the NIHR, spent £65.3 million on research into neurological conditions.
Asked by: Dean Russell (Conservative - Watford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that the Major Conditions Strategy includes additional material on mental health.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Since announcing the Major Conditions Strategy in January 2023, we have been working with a range of stakeholders in the health and care system, including those representing mental health conditions. This is to identify what would make the most difference in tackling the six major condition groups, which includes mental health, that account for approximately 60% of ill-health and early death in England.
The strategy will consider how we can ensure that mental health is effectively integrated with physical health, as well as delivering preventative, proactive, and person-centred care across the major conditions. This strategy does not seek to describe everything that is being done or could be done to meet the challenges of individual conditions in isolation, it instead focuses on the changes likely to make the most difference across the six groups of major conditions.
Asked by: Dean Russell (Conservative - Watford)
Question to the Department for Environment, Food and Rural Affairs:
To ask the Secretary of State for Environment, Food and Rural Affairs, whether his Department is taking steps to help encourage companies to transition away from testing products on animals.
Answered by Mark Spencer - Minister of State (Department for Environment, Food and Rural Affairs)
Animal testing of chemical substances is permitted under UK REACH only as a measure of last resort; this principle is reinforced by the Environment Act 2021. Moreover, UK REACH states that test methods should be regularly reviewed with a view to reducing animal testing and it encourages the use of alternative methods. Testing and assessment of final products is not a part of UK REACH.
The Veterinary Medicines Directorate (VMD) is the UK regulatory authority for veterinary medicinal products. The VMD assesses applications submitted by the veterinary pharmaceutical industry in line with national and international regulations and guidance to ensure safe and effective veterinary medicines of good quality are marketed. These requirements may therefore necessitate animal testing either to develop and register new veterinary medicines or for routine product quality control, to ensure the continued quality, safety and efficacy batch to batch. Non-animal tests are not always available and the VMD is committed to phasing out the use of animals for testing purposes where possible, in accordance with the principles of 3Rs (Replacement, Reduction, Refinement). Furthermore, the UK is a signatory to the European Pharmacopoeia (which sets minimum quality standards of medicines) and the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes and this commitment to the 3Rs is also enshrined in the UK’s Animals (Scientific Procedures) Act 1986 under which scientific procedures in animals are regulated.
The Minister of State for Science, Research and Innovation (the hon. Member for Arundel and South Downs, Andrew Griffith) recently announced that the Government will publish a plan to accelerate the development, validation and uptake of technologies and methods to reduce reliance on the use of animals in science, which will be published in the summer. He also requested that we double our investment in research to achieve these approaches next year to £20 million across the system in 2024/25.
Asked by: Dean Russell (Conservative - Watford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the effectiveness of Early Intervention Hubs.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
In July 2023, the Department secured just under £5 million from HM Treasury’s Shared Outcomes Fund, for a project to boost and evaluate the impact of 10 early support hubs. The Department has since provided an additional £3 million to increase the number of hubs being funded across the country to 24.
Crucially, alongside boosting 24 hubs, the funding is also being used to evaluate the impact of the services, and inform any potential expansion of the model in the future. The evaluation aims to report its findings by Summer 2025.
Asked by: Dean Russell (Conservative - Watford)
Question to the Department for Education:
To ask the Secretary of State for Education, what progress her Department has made on delivering a mental health support lead within primary and secondary schools.
Answered by David Johnston - Parliamentary Under-Secretary (Department for Education)
The department has offered all state-funded schools and colleges in England a grant to train a senior mental health lead by 2025. The department continues to deliver on the commitments that it made in the government’s 2018 response to the consultation on 'Transforming children and young people's mental health provision: a green paper' and to deliver on next steps. The government’s response to the consultation can be found here: https://www.gov.uk/government/consultations/transforming-children-and-young-peoples-mental-health-provision-a-green-paper.
As at 30 November 2023, 15,100 schools and colleges had taken up this offer and claimed a grant, which represents 63% of the total number of settings that are eligible to apply. Breakdowns of the data, including by setting type, can be found in the department’s transparency data release which has been updated annually since the programme started and is available at: https://www.gov.uk/government/publications/transforming-children-and-young-peoples-mental-health-provision.
A list of schools and colleges receiving a senior mental health lead training grant is also published and updated throughout the year, which can be found here: https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fassets.publishing.service.gov.uk%2Fmedia%2F65b0cb50160765001118f741%2FSenior_mental_health_lead_training_January_2024_Update.ods&wdOrigin=BROWSELINK.